Dr. Wenjuan Yao is a distinguished researcher and faculty member at Nantong University, China, widely recognized for her impactful contributions to pharmacology, toxicology, and neurodegenerative disease research. She holds a strong academic foundation in pharmaceutical sciences, further strengthened through extensive training in molecular pharmacology and biomedical research. Dr. Yao’s work centers on elucidating cellular and mitochondrial mechanisms underlying chronic diseases, with particular expertise in neuroinflammation, vascular remodeling, metabolic dysfunction, and natural product pharmacology. She has authored 39 peer-reviewed publications, which have collectively garnered over 856 citations from 747 citing documents, reflecting her growing international influence and an h-index of 19. Her recent publications include notable studies on astrocytic glycolytic dysfunction in Alzheimer’s disease models, the pharmacological and toxicological profiles of ginkgolic acids, and the role of AKAP1 in vascular smooth muscle cell modulation, showcasing her ability to bridge molecular insights with therapeutic potential. Dr. Yao has collaborated with more than 100 co-authors, demonstrating her active participation in multidisciplinary research networks spanning neurology, pharmacotherapy, traditional medicine, and cellular biology. Her work significantly advances scientific understanding of mitochondrial dynamics, secondary plant metabolites, and disease-modifying interventions, contributing to improved translational strategies for complex disorders. Dr. Yao has been recognized through institutional and scholarly acknowledgments for her research excellence and continues to contribute to the scientific community through editorial and peer-review roles in leading journals across biomedicine and pharmacology. Her research not only deepens mechanistic knowledge but also supports the development of safer, more effective therapeutic agents, underscoring her commitment to advancing global health and biomedical innovation.

Prof. Yoon-jin Lee, a distinguished scholar at Soonchunhyang University, Asan, South Korea, is a leading researcher whose work spans cancer biology, metabolomics, natural product chemistry, and regenerative medicine, as reflected in her 1,255 citations, 72 published documents, and an h-index of 22. Her scholarship demonstrates a sustained commitment to advancing molecular insights into cancer progression, exploring bioactive natural compounds, and innovating therapeutic strategies using both in vitro and in vivo models. Prof. Lee has contributed significantly to the understanding of apoptosis, necroptosis, metabolic reprogramming, and microenvironment-driven cancer behavior, with several recent works investigating polyphenol-mediated anticancer mechanisms, extracellular vesicle–induced metabolic shifts, and advanced analytical approaches such as qNMR and metabolomics for evaluating medicinal plant derivatives. Beyond oncology, her research extends to tissue engineering and musculoskeletal regeneration, including cutting-edge studies on bioprinted collagen constructs and microcurrent-induced muscle repair. Her multidisciplinary approach—integrating analytical chemistry, cell biology, and biomedical engineering—has positioned her as a vital contributor to translational research that bridges laboratory discoveries with potential clinical applications. Across 131 co-authors and diverse international collaborations, her studies reflect a strong global research footprint and a commitment to scientific rigor, innovation, and societal impact. With a growing publication record that continues to influence emerging methodologies and therapeutic concepts, Prof. Lee remains a key figure advancing the future of biomedical research and interdisciplinary scientific development.